Clinical trial
A Single Ascending Dose Study to Assess the Safety and Pharmacokinetics of Intra-articular AVD275 Injection in Patients With Osteoarthritis of the Knee
NCT07338266 is registered in ClinicalTrials.gov with Avidence Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single Ascending Dose Study to Assess the Safety and Pharmacokinetics of Intra-articular AVD275 Injection in Patients With Osteoarthritis of the Knee
- Lead sponsor
- Avidence Therapeutics
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- January 22, 2026
- Completion date
- December 31, 2026
- Enrollment
- 15 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
osteoarthritis of the knee